On Aug. 9, 1997, the U.S. Food and Drug Administration (FDA) announced a policy that allowed pharmaceutical companies the expansion of direct-to-consumer advertising into broadcast and electronic media.

The adequate provision requirement could be fulfilled by referring consumers to a physician, a website, a toll-free telephone number, and a print advertisement.